Literature DB >> 11879811

Age-related changes in hypocretin (orexin) immunoreactivity in the cat brainstem.

Jian Hua Zhang1, Sharon Sampogna, Francisco R Morales, Michael H Chase.   

Abstract

Terminals of hypothalamic hypocretin-containing neurons are observed within brainstem nuclei involved in the control of sleep and wakefulness. Because aged humans, cats and other species exhibit changes in sleep and wakefulness in old age, we were interested in examining age-related changes in hypocretin/orexin projections to the following brainstem regions which are associated with the regulation of sleep and wakefulness: the dorsal raphe nucleus, the laterodorsal tegmental nucleus, the pedunculo-pontine tegmental nucleus and the locus coeruleus. Based upon the results of immunohistochemical determinations, in all the regions examined, round or oval "spot-like" structures were observed in aged cats. Many of these "spot-like" structures resembled enlarged varicosities of a nature that would be expected to disrupt hypocretin neurotransmission. In addition, a site-specific decrease in immunostaining was observed in the locus coeruleus in old cats compared with adult controls; this result likely reflects a decrease in the number of labeled fibers, which indicates that there occurs a degeneration of hypocretinergic function in conjunction with old age. The proceeding changes may account for some of sleep-wake disturbance which are observed in aged animals as well as elderly humans.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11879811     DOI: 10.1016/s0006-8993(02)02240-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  18 in total

1.  Age- and gender-specific changes of hypocretin immunopositive neurons in C57Bl/6 mice.

Authors:  Sara E Brownell; Bruno Conti
Journal:  Neurosci Lett       Date:  2010-02-01       Impact factor: 3.046

Review 2.  Orexin/hypocretin modulation of the basal forebrain cholinergic system: Role in attention.

Authors:  J Fadel; J A Burk
Journal:  Brain Res       Date:  2009-08-21       Impact factor: 3.252

3.  Reduction of the molecular chaperone binding immunoglobulin protein (BiP) accentuates the effect of aging on sleep-wake behavior.

Authors:  Nirinjini Naidoo; Jingxu Zhu; Raymond J Galante; Jie Lian; Ewa Strus; Amy Lee; Brendan T Keenan; Allan I Pack
Journal:  Neurobiol Aging       Date:  2018-04-30       Impact factor: 4.673

4.  Increased acetylcholine and glutamate efflux in the prefrontal cortex following intranasal orexin-A (hypocretin-1).

Authors:  Coleman B Calva; Habiba Fayyaz; Jim R Fadel
Journal:  J Neurochem       Date:  2018-01-12       Impact factor: 5.372

5.  Age-related loss of orexin/hypocretin neurons.

Authors:  B A Kessler; E M Stanley; D Frederick-Duus; J Fadel
Journal:  Neuroscience       Date:  2011-01-22       Impact factor: 3.590

6.  Endoplasmic reticulum stress in wake-active neurons progresses with aging.

Authors:  Nirinjini Naidoo; Jingxu Zhu; Yan Zhu; Polina Fenik; Jie Lian; Ray Galante; Sigrid Veasey
Journal:  Aging Cell       Date:  2011-04-12       Impact factor: 9.304

Review 7.  Sleep in older adults and in subjects with dementia.

Authors:  Helmut Frohnhofen; Jeanina Schlitzer; Nikolaus Netzer
Journal:  Z Gerontol Geriatr       Date:  2017-07-18       Impact factor: 1.281

Review 8.  Intranasal administration of orexin peptides: Mechanisms and therapeutic potential for age-related cognitive dysfunction.

Authors:  Coleman B Calva; Jim R Fadel
Journal:  Brain Res       Date:  2018-08-24       Impact factor: 3.252

9.  The wake-promoting effects of hypocretin-1 are attenuated in old rats.

Authors:  Stephen R Morairty; Jonathan Wisor; Kristy Silveira; William Sinko; Thomas S Kilduff
Journal:  Neurobiol Aging       Date:  2009-09-24       Impact factor: 4.673

10.  Systemic and intrabasalis administration of the orexin-1 receptor antagonist, SB-334867, disrupts attentional performance in rats.

Authors:  Karen E Boschen; Jim R Fadel; Joshua A Burk
Journal:  Psychopharmacology (Berl)       Date:  2009-07-03       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.